Cargando…

Emerging role of engineered exosomes in nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. NAFLD comprises a continuum of liver abnormalities from nonalcoholic fatty liver to nonalcoholic steatohepatitis, and can even lead to cirrhosis and liver cancer. However, a well-established treatment for NA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Jian, Xu, Chen, Xu, Ming, He, Xiao-Yue, Li, Wei-Na, He, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075012/ https://www.ncbi.nlm.nih.gov/pubmed/37034232 http://dx.doi.org/10.4254/wjh.v15.i3.386

Ejemplares similares

Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics
por: Di Sessa, Anna, et al.
Publicado: (2021)

Mediterranean diet and nonalcoholic fatty liver disease
por: Anania, Caterina, et al.
Publicado: (2018)

Associations between nonalcoholic fatty liver disease and ischemic stroke
por: Alkagiet, Stelina, et al.
Publicado: (2018)

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
por: Pirola, Carlos J, et al.
Publicado: (2018)

Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
por: Mattos, Ângelo Z, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic
por: Ahmed, Musaab, et al.
Publicado: (2021)

Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value
por: Li, Yu-Qi, et al.
Publicado: (2023)

Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status
por: Kiseleva, Yana V, et al.
Publicado: (2023)

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
por: Chackelevicius, Carla Melisa, et al.
Publicado: (2016)

Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis
por: Zhang, Yang, et al.
Publicado: (2021)

Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system
por: Pirola, Carlos Jose, et al.
Publicado: (2021)

Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
por: Ueno, Masayuki, et al.
Publicado: (2022)

Role of exosomal long non-coding RNAs in colorectal cancer
por: Sun, Ru, et al.
Publicado: (2021)

Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
por: Pacifico, Lucia, et al.
Publicado: (2018)

Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view
por: Chen, Hui-Ting, et al.
Publicado: (2020)

Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
por: Wibawa, I Dewa Nyoman, et al.
Publicado: (2023)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

Role of noncoding RNAs in liver fibrosis
por: Li, Qing-Yuan, et al.
Publicado: (2023)

The role of microRNAs in liver cancer progression
por: Huang, S, et al.
Publicado: (2011)

Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
por: Mattos, Ângelo Z, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice
por: Ding, Jian, et al.
Publicado: (2023)

Roles of vitamin A in the regulation of fatty acid synthesis
por: Yang, Fu-Chen, et al.
Publicado: (2021)

A role of peroxisome proliferator‐activated receptor γ in non‐alcoholic fatty liver disease
por: Skat‐Rørdam, Josephine, et al.
Publicado: (2019)

Emerging role of autophagy in colorectal cancer: Progress and prospects for clinical intervention
por: Ma, Tian-Fei, et al.
Publicado: (2023)

Fatty liver and celiac disease: Why worry?
por: Narciso-Schiavon, Janaina Luz, et al.
Publicado: (2023)

Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
por: Yousef, Mohamad H, et al.
Publicado: (2017)

The role of complement in nonalcoholic fatty liver disease
por: Guo, Zhenya, et al.
Publicado: (2022)

Potential regulatory effects of stem cell exosomes on inflammatory response in ischemic stroke treatment
por: Chen, Na, et al.
Publicado: (2023)

Growing challenge of post-liver transplantation non-alcoholic fatty liver disease
por: Kalogirou, Maria Styliani, et al.
Publicado: (2022)

Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome
por: Sheng, Wei, et al.
Publicado: (2022)

Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence
por: Jeyakumar, Shanmugam Murugaiha, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

COVID-19 and pediatric fatty liver disease: Is there interplay?
por: Di Sessa, Anna, et al.
Publicado: (2021)

Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis
por: Seen, Tasur Kumar, et al.
Publicado: (2021)

Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
por: Gill, Madeleine G, et al.
Publicado: (2020)

Mesenchymal stem cell-derived exosomes: An emerging therapeutic strategy for normal and chronic wound healing
por: Zeng, Qin-Lu, et al.
Publicado: (2021)

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
por: Wong, Carrie R, et al.
Publicado: (2016)

Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Said, Adnan, et al.
Publicado: (2017)

Obese children with fatty liver: Between reality and disease mongering
por: Ranucci, Giusy, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4pve9b056jc3tdamuinv4qsp7s